Prestige Consumer Healthcare Inc.

A$66.99
AUD
Last updated on --.
24h volume933.09K
24h highest67.7879 AUD
24h lowest66.2533 AUD
24h Price movement+0.04%

PBH recent prices

24 Hours
+0.04%+A$0.027902
30 days
-17.47%-A$14.21
60 days
-18.95%-A$15.66
90 days
-31.47%-A$30.83

Key data

Previous close66.9648 AUD
Market cap3.12B AUD
Volume933.09K
P/E ratio11.750000
Dividend yield (TTM)0.00%
Dividend amount0.43597 AUD
Next ex-dividend date27 Dec 2013
Next payment date15 Jan 2014
EPS diluted (TTM)5.6083 AUD
Net income (FY)265.49M AUD
Revenue (FY)1.52B AUD
Last report date14 May 2026

About Prestige Consumer Healthcare Inc.

PHARMACEUTICAL PREPARATIONS
HeadquartersTARRYTOWN
Employees (FY)890.00
Revenue per employee (FY)1.71M AUD
Net income per employee (FY)298.30K AUD
Listed onNew York Stock Exchange
Official website

PBH conversion tables

PBHPBH
AUDAUD
0.5 PBH33.49 AUD
1 PBH66.99 AUD
5 PBH334.96 AUD
10 PBH669.92 AUD
AUDAUD
PBHPBH
0.5 AUD0.0074635 PBH
1 AUD0.014927 PBH
5 AUD0.074635 PBH
10 AUD0.14927 PBH

FAQ

PBH is trading at A$66.99, +0.04% over the last 24 hours. Track live moves on the price chart at the top of this page.
The PBH stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. PBH is currently trading at A$66.99, +0.04% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on PBH price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. PBH's P/E ratio is currently 11.750000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from PBH; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against PBH's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Prestige Consumer Healthcare Inc.'s market cap is currently 3.12B AUD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume933.09K
24h highest67.7879 AUD
24h lowest66.2533 AUD
24h Price movement+0.04%
PBHPBH
AUDAUD
Start trade with PBH Perpetual